There are no adequate and well-controlled studies of VEVYE administration to nursing women to inform drug-associated risk.

Cyclosporine is known to be excreted in human milk following systemic administration but excretion in human milk after topical treatment has not been investigated. VEVYE doses are approximately 4,700 times lower than recommended oral doses of cyclosporine, with blood concentrations being undetectable after topical administration. However, caution should be exercised when VEVYE is administered to a nursing woman.

Please see the Important Safety Information and the Full Prescribing Information for additional safety details.